CN Patent
CN103649093B — 取代的咪唑并吡啶和咪唑并哒嗪及其用途
Assigned to Bayer Medicine Co Stock Co · Expires 2017-07-07 · 9y expired
What this patent protects
本发明涉及新的取代的咪唑并吡啶和咪唑并哒嗪,涉及其制备方法,涉及其单独或结合的用于治疗和/或预防疾病的用途,以及涉及其用于制备治疗和/或预防疾病(特别是用于治疗和/或预防心血管疾病)的药剂的用途。
USPTO Abstract
本发明涉及新的取代的咪唑并吡啶和咪唑并哒嗪,涉及其制备方法,涉及其单独或结合的用于治疗和/或预防疾病的用途,以及涉及其用于制备治疗和/或预防疾病(特别是用于治疗和/或预防心血管疾病)的药剂的用途。
Drugs covered by this patent
- Adempas (RIOCIGUAT) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.